OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,518,121 | +20.9% | 3,520,344 | +3.3% | 0.00% | – |
| Q2 2023 | $11,178,920 | +496.9% | 3,408,207 | +369.5% | 0.00% | – |
| Q1 2023 | $1,872,789 | +39.3% | 725,887 | +0.5% | 0.00% | – |
| Q4 2022 | $1,343,996 | -36.9% | 722,579 | -37.6% | 0.00% | – |
| Q3 2022 | $2,131,000 | -15.7% | 1,157,755 | -1.5% | 0.00% | – |
| Q2 2022 | $2,527,000 | -30.2% | 1,175,221 | +2.0% | 0.00% | – |
| Q1 2022 | $3,619,000 | -1.8% | 1,152,309 | +0.4% | 0.00% | – |
| Q4 2021 | $3,684,000 | -4.9% | 1,147,879 | -0.4% | 0.00% | – |
| Q3 2021 | $3,875,000 | -17.6% | 1,153,040 | -4.1% | 0.00% | – |
| Q2 2021 | $4,703,000 | -68.4% | 1,202,730 | -67.5% | 0.00% | – |
| Q1 2021 | $14,882,000 | +88.9% | 3,701,688 | +8.5% | 0.00% | – |
| Q4 2020 | $7,880,000 | -50.3% | 3,411,733 | +23.6% | 0.00% | -100.0% |
| Q3 2020 | $15,841,000 | -26.2% | 2,759,691 | -5.3% | 0.00% | 0.0% |
| Q2 2020 | $21,477,000 | +1370.0% | 2,914,107 | +494.7% | 0.00% | – |
| Q1 2020 | $1,461,000 | -21.9% | 490,003 | +8.7% | 0.00% | – |
| Q4 2019 | $1,871,000 | +328.1% | 450,746 | +234.4% | 0.00% | – |
| Q3 2019 | $437,000 | +67.4% | 134,798 | -4.4% | 0.00% | – |
| Q2 2019 | $261,000 | -77.9% | 141,062 | -78.8% | 0.00% | – |
| Q1 2019 | $1,181,000 | -65.5% | 666,900 | -52.9% | 0.00% | – |
| Q4 2018 | $3,424,000 | -59.4% | 1,414,696 | -4.9% | 0.00% | – |
| Q3 2018 | $8,435,000 | -26.9% | 1,487,755 | +0.6% | 0.00% | -100.0% |
| Q2 2018 | $11,534,000 | +20.1% | 1,478,855 | +8.9% | 0.00% | – |
| Q1 2018 | $9,606,000 | -8.5% | 1,358,459 | +27.8% | 0.00% | – |
| Q4 2017 | $10,494,000 | +12.3% | 1,063,212 | -2.5% | 0.00% | – |
| Q3 2017 | $9,343,000 | -20.5% | 1,090,127 | -2.8% | 0.00% | -100.0% |
| Q2 2017 | $11,759,000 | – | 1,121,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |